Eli Lilly is set to expand the reach of its popular diabetes and weight-loss medication, Mounjaro, into sizable markets like China, India, Brazil, and Mexico by 2025, as announced by CFO Lucas Montarce at the Leerink Partners Global Healthcare Conference.
About the Author
